688065 Stock Overview
A bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Cathay Biotech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥42.02 |
| 52 Week High | CN¥56.98 |
| 52 Week Low | CN¥32.48 |
| Beta | 0.63 |
| 1 Month Change | -4.57% |
| 3 Month Change | 28.11% |
| 1 Year Change | -20.87% |
| 3 Year Change | -67.00% |
| 5 Year Change | n/a |
| Change since IPO | -62.53% |
Recent News & Updates
Cathay Biotech's (SHSE:688065) Profits Appear To Have Quality Issues
Nov 07
What Cathay Biotech Inc.'s (SHSE:688065) 38% Share Price Gain Is Not Telling You
Oct 22Cathay Biotech (SHSE:688065) Could Be Struggling To Allocate Capital
Oct 20Recent updates
Cathay Biotech's (SHSE:688065) Profits Appear To Have Quality Issues
Nov 07What Cathay Biotech Inc.'s (SHSE:688065) 38% Share Price Gain Is Not Telling You
Oct 22Cathay Biotech (SHSE:688065) Could Be Struggling To Allocate Capital
Oct 20Cathay Biotech (SHSE:688065) Seems To Use Debt Quite Sensibly
Sep 29Cathay Biotech Inc.'s (SHSE:688065) Share Price Not Quite Adding Up
Sep 07There Are Reasons To Feel Uneasy About Cathay Biotech's (SHSE:688065) Returns On Capital
Jun 19Cathay Biotech (SHSE:688065) Has A Somewhat Strained Balance Sheet
May 28What Cathay Biotech Inc.'s (SHSE:688065) 27% Share Price Gain Is Not Telling You
May 07We Think That There Are More Issues For Cathay Biotech (SHSE:688065) Than Just Sluggish Earnings
May 06Shareholder Returns
| 688065 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | -4.8% | -2.3% | -1.2% |
| 1Y | -20.9% | 0.7% | 11.8% |
Return vs Industry: 688065 underperformed the CN Chemicals industry which returned 0.7% over the past year.
Return vs Market: 688065 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 688065 volatility | |
|---|---|
| 688065 Average Weekly Movement | 9.3% |
| Chemicals Industry Average Movement | 8.2% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688065 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688065's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 1,803 | Xiucai Liu | www.cathaybiotech.com |
Cathay Biotech Inc., a bio-manufacturing technology company, researches, develops, produces, and sells bio-based materials in China and internationally. It offers biological long-chain diacids comprising sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine. The products are used in various applications, including textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, and other industries.
Cathay Biotech Inc. Fundamentals Summary
| 688065 fundamental statistics | |
|---|---|
| Market cap | CN¥24.43b |
| Earnings (TTM) | CN¥397.82m |
| Revenue (TTM) | CN¥2.76b |
61.4x
P/E Ratio8.8x
P/S RatioIs 688065 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688065 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.76b |
| Cost of Revenue | CN¥1.92b |
| Gross Profit | CN¥846.65m |
| Other Expenses | CN¥448.84m |
| Earnings | CN¥397.82m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.68 |
| Gross Margin | 30.63% |
| Net Profit Margin | 14.39% |
| Debt/Equity Ratio | 8.7% |
How did 688065 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield28%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 12:21 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cathay Biotech Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Junjun Zhu | Haitong International Research Limited |